Eli Lilly and Co (LLY.N) has received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, the drugmaker said in a filing on Thursday. Read More
Eli Lilly and Co (LLY.N) has received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, the drugmaker said in a filing on Thursday. Read More
